SeaStar Medical (ICU) Fundamental Analysis: Revenue, Earnings & Valuation

0.87 / 10

Underperform

Fundamental metrics rate Underperform with a 0.9/10 score, reflecting subpar quality. Profit‑MV and Cash‑UP are modestly bullish, while Cash‑MV, ROE, ROA and other profitability ratios are deeply negative, placing the company in the lowest performance groups.

Analysis Checks(3/10)

ROA (%)

Value-91.60

Score0/3

Weight15.37%

1M Return-6.12%

Annualized return on equity (%)

Value-265.66

Score0/3

Weight14.69%

1M Return-5.73%

Profit-MV

Value0.41

Score2/3

Weight-14.05%

1M Return3.26%

Cash-UP

Value-0.01

Score2/3

Weight12.82%

1M Return-3.92%

Annualized net profit margin on total assets (%)

Value-122.13

Score0/3

Weight15.37%

1M Return-6.12%

ROE (diluted) (%)

Value-80.65

Score0/3

Weight15.43%

1M Return-5.82%

Asset-MV

Value-0.48

Score0/3

Weight11.26%

1M Return-3.34%

ROE (%)

Value-199.25

Score0/3

Weight14.69%

1M Return-5.73%

Cash-MV

Value-0.09

Score1/3

Weight11.05%

1M Return-3.56%

Net profit / Total profit (%)

Value100.03

Score2/3

Weight3.36%

1M Return-0.89%

Is ICU undervalued or overvalued?

ICU scores 0.87/10 on fundamentals and holds a Premium valuation at present. Backed by its -295.15% ROE, -984.60% net margin, -0.92 P/E ratio, 1.07 P/B ratio, and 91.17% earnings growth, these metrics solidify its Underperform investment rating.